| 2026-08-17 | Press release | Elanco Animal Health Announces Common Stock and Tangible Equity Unit Offerings Associated with Financing Acquisition of Bayer’s Animal Health Business |
| 2026-08-17 | Press release | Elanco Animal Health Announces Pricing and Upsize of Senior Secured Term Loan Facilities |
| 2026-08-17 | Press release | Elanco to Participate in Cowen Health Care Conference |
| 2026-08-17 | Press release | Elanco Provides Business Update Related to COVID-19 |
| 2026-08-17 | Press release | The Elanco Foundation Announces Efforts to Support Food Security Amidst COVID-19 Crisis |
| 2026-08-17 | Press release | Elanco Animal Health Submits Form CO to European Commission |
| 2026-08-17 | Press release | Elanco to Participate in the Bank of America Securities Health Care Conference |
| 2026-08-17 | Press release | Elanco Achieves Important Innovation Milestones, Momentum to Start 2021 |
| 2026-08-17 | Press release | Elanco Animal Health Reports Fourth Quarter and Full Year 2020 Results |
| 2026-08-17 | Press release | Elanco to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference |
| 2026-08-17 | Press release | Elanco to Participate in Morgan Stanley 20th Annual Global Healthcare Conference |
| 2026-08-17 | Press release | PDF Version |
| 2026-08-07 | Press release | Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Applicatio |
| 2026-08-05 | Transcript | Q2 FY26 earnings call transcript |
| 2026-08-05 | Press release | PDF Version · Q2 2026 |
| 2026-08-05 | Press release | Elanco Animal Health Reports Second Quarter 2026 Results |
| 2026-08-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-05 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-05 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-31 | Press release | PDF Version · FY 2025 |
| 2026-07-22 | Press release | PDF Version |
| 2026-07-22 | Press release | Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simpari |
| 2026-07-08 | Press release | PDF Version · Q2 2026 |
| 2026-07-08 | Press release | Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement |
| 2026-06-19 | Press release | Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results |
| 2026-06-18 | Press release | PDF Version |
| 2026-06-18 | Press release | Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health |
| 2026-06-15 | Press release | PDF Version |
| 2026-06-15 | Press release | Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Lept |
| 2026-06-04 | Press release | PDF Version |
| 2026-06-04 | Press release | Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm |
| 2026-06-03 | Press release | PDF Version |
| 2026-06-03 | Press release | New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience |
| 2026-06-02 | Deck | William-Blair-ELAN-2-June-2026-vF |
| 2026-05-27 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-18 | Press release | PDF Version |
| 2026-05-18 | Press release | Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion |
| 2026-05-14 | Press release | PDF Version |
| 2026-05-14 | Press release | Elanco to Participate in Upcoming Investor Conferences |
| 2026-05-06 | Press release | Elanco Animal Health Reports First Quarter 2026 Results Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target |